Literature DB >> 3567145

Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase mRNA levels by L-triiodothyronine.

C E Sample, L C Pendleton, G C Ness.   

Abstract

In hypophysectomized rats, hepatic 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity, immunoreactive 97-kilodalton (97-kDa) protein, and mRNA were all reduced to undetectable levels. Administration of triiodothyronine (T3) resulted in large increases in all three after a 36-h lag period. HMG-CoA reductase activity, immunoreactive 97-kDa protein levels, and reductase mRNA levels were tightly correlated. Feeding hypophysectomized rats diets containing the bile acid sequestrant colestipol, together with the potent reductase inhibitor mevinolin, resulted in an increase in HMG-CoA reductase activity similar to that seen with T3 but a lesser stimulation of reductase mRNA levels. These results suggest that agents which cause depletion of mevalonate-derived products may share in part with T3 a common mechanism for increasing levels of HMG-CoA reductase activity in order to satisfy cellular needs for these products. Dexamethasone treatment, which is known to prevent the T3-mediated stimulation of reductase activity, caused a marked decrease in 97-kDa immunoreactive material but had little effect on reductase mRNA levels.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3567145     DOI: 10.1021/bi00377a011

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

1.  Loss of NADPH during assays of HMG-CoA reductase: implications and approaches to minimize errors.

Authors:  G C Ness; L C Pendleton; A S Pendleton
Journal:  Lipids       Date:  1987-06       Impact factor: 1.880

2.  Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys.

Authors:  B R Ito; B-H Zhang; E E Cable; X Song; J M Fujitaki; D A MacKenna; C E Wilker; B Chi; P D van Poelje; D L Linemeyer; M D Erion
Journal:  Br J Pharmacol       Date:  2009-01-22       Impact factor: 8.739

3.  Thyroid hormone receptor agonists reduce serum cholesterol independent of the LDL receptor.

Authors:  Jean Z Lin; Alexandro J Martagón; Willa A Hsueh; John D Baxter; Jan-Åke Gustafsson; Paul Webb; Kevin J Phillips
Journal:  Endocrinology       Date:  2012-10-19       Impact factor: 4.736

4.  Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans.

Authors:  Ylva Bonde; Olof Breuer; Dieter Lütjohann; Stefan Sjöberg; Bo Angelin; Mats Rudling
Journal:  J Lipid Res       Date:  2014-08-29       Impact factor: 5.922

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.